Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Bortezomib × 90 days × Clear all

Phase

Status

Active not recruiting 28 Recruiting 25 Completed 6 Not yet recruiting 4 Withdrawn 1 Terminated 1 Suspended 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 1

Interventions

pembrolizumab 34 Nivolumab 12 Carboplatin 10 venetoclax 9 Specimen Handling 9 Biopsy 9 Gemcitabine 8 fludarabine 7 atezolizumab 7 Radiosurgery 7 Pemetrexed 7 Magnetic Resonance Spectroscopy 7 Azacitidine 7 olaparib 6 durvalumab 6 Surveys and Questionnaires 6 Paclitaxel 6 Docetaxel 6 Cyclophosphamide 6 Trastuzumab 5 Interviews as Topic 5 Fulvestrant 5 Drug Therapy 5 tislelizumab 4 binimetinib 4 X-Rays 4 Radiotherapy 4 Radiation 4 Ipilimumab 4 Injections 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05556616 2026-01-29

iinnovate-2

Teva Branded Pharmaceutical Products R&D, Inc.

Phase 1 Terminated

15 enrolled 15 charts

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡